AIM CONCEPT INTEGRATION
4th Year MBBS
Neuroscience
Neuroscience
General Anaesthetics and Perioperative Pharmacology
Connect the major pharmacological concepts into one rapid revision pathway: drug delivery → CNS effect → anaesthetic state → clinical selection → adverse effects → recovery.
Concept Integration structure follows the supplied AIM three-section framework. :contentReference[oaicite:0]{index=0}
1. THE TOPIC IN ONE CONNECTED FLOW
General anaesthesia depends on getting an effective drug concentration to the brain, producing the required CNS effects and combining different drug actions when one agent cannot provide everything. The choice of inhalational or intravenous drug then determines induction speed, cardiovascular effects, analgesia, important adverse effects and the pattern of recovery.
START
Anaesthetic Drug
Inhalational or intravenous administration
→
Brain Delivery
Blood carries drug to the CNS
→
Neuronal Effect
↑ inhibitory signalling or ↓ excitation
→
Anaesthetic State
Unconsciousness ± analgesia ± amnesia
→
Balanced Anaesthesia
Add analgesic, sedative or muscle-relaxant components as needed
→
Recovery
Brain concentration falls by redistribution or elimination
Two pharmacokinetic pathways determine how this flow behaves:
Inhalational agents
Low blood:gas coefficient → rapid rise in brain partial pressure → faster induction and recovery.
MAC ↓ → anaesthetic potency ↑.
Intravenous agents
Rapid cerebral delivery → fast unconsciousness.
For thiopentone: brain → peripheral tissues → falling brain level → awakening by redistribution.
2. KEY CLINICAL CONNECTIONS
Inhalational Agent Selection
Low blood solubility → fast adjustment of brain concentration → rapid emergence.
Sevoflurane → non-pungent → smoother inhalational induction.
Desflurane → extremely rapid kinetics → rapid recovery, but airway irritation.
IV Drug Selection
Propofol → GABA-mediated hypnosis → rapid recovery + antiemetic effect → hypotension/apnea.
Etomidate → hypnosis with relative cardiovascular stability → useful when haemodynamic depression is undesirable → adrenal suppression limits repeated use.
Ketamine and Malignant Hyperthermia
Ketamine → NMDA blockade → dissociative anaesthesia + analgesia → sympathetic stimulation and emergence reactions.
Volatile trigger in susceptible patient → excessive skeletal-muscle Ca²⁺ release → hypermetabolism → dantrolene reduces abnormal Ca²⁺ release.
3. AIM HIGH-YIELD INTEGRATION REVIEW
⭐ Blood:gas coefficient → speed: lower blood solubility allows faster induction, adjustment and recovery.
⭐ MAC → potency: lower MAC means a smaller alveolar concentration is required, so potency is greater.
N₂O → rapid diffusion: useful analgesia + second-gas effect; rapid washout can cause diffusion hypoxia and the gas can expand closed spaces.
Halothane → characteristic toxicity: myocardial depression and catecholamine sensitization connect with hypotension and arrhythmias; hepatic injury is another important concern.
⭐ Thiopentone → redistribution: rapid brain entry produces unconsciousness, then movement into peripheral tissues lowers brain concentration and terminates a single dose.
Midazolam + fentanyl: sedation/amnesia and opioid analgesia complement each other, but combined CNS depression can worsen respiratory depression.
TIVA → IV maintenance: intravenous hypnotic + analgesic component maintains anaesthesia without a volatile maintenance agent, so accurate IV delivery is essential.
⭐ Malignant hyperthermia: volatile trigger → excessive skeletal-muscle Ca²⁺ release → rigidity, rising CO₂ and hypermetabolism → stop trigger + dantrolene and supportive treatment.
AIM Exam Trap: Do not confuse MAC with the blood:gas partition coefficient. MAC reflects anaesthetic potency; blood:gas solubility mainly determines the speed of induction and recovery.